Profile data is unavailable for this security.
About the company
Holista CollTech Ltd is a research-driven biotech company. The Company is focused on researching, developing, manufacturing, and marketing health-style products. The Company operates through four segments: Supplements, Ovine Collagen, Infection Control Solutions, and Food Ingredients. The Supplements segment is involved in the manufacture and wholesale distribution of dietary supplements. The Ovine collagen segment is involved in the manufacture and distribution of cosmetic-grade collagen. The Food ingredients segment is involved in the manufacture and wholesale distribution of healthy food ingredients. The Infection control Solutions segment is involved in the infection control solutions. The Company’s products include LOGIC Sweet, Super Bio Silver, OVICOLL, OVINEX, low-GI bread, low-GI noodle and spaghetti, 80Less sugar, Low Fat Chip, and health supplements. The Company's subsidiaries include Holista Biotech Sdn Bhd, Alterni (M) Sdn Bhd, Revonutrix Sdn Bhd, and others.
- Revenue in AUD (TTM)5.95m
- Net income in AUD-4.81m
- Incorporated2000
- Employees3.00
- LocationHolista CollTech Ltd283 Rokeby RdSUBIACO 6008AustraliaAUS
- Phone+61 86141-3500
- Fax+61 86141-3599
- Websitehttps://www.holistaco.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nutritional Growth Solutions Ltd | 4.50m | -4.36m | 753.68k | -- | -- | -- | -- | 0.1675 | -0.024 | -0.024 | 0.0233 | -0.0011 | 1.51 | 2.19 | 61.53 | -- | -145.93 | -- | -303.09 | -- | 28.22 | 42.47 | -96.95 | -152.30 | 0.1888 | -- | 1.96 | -- | 1.26 | 41.61 | 31.91 | -- | -- | -- |
| Holista Colltech Limited | 5.95m | -4.81m | 1.39m | 3.00 | -- | -- | -- | 0.2343 | -0.0172 | -0.0172 | 0.0213 | -0.0071 | 1.35 | 2.49 | 4.70 | -- | -111.49 | -42.59 | -347.69 | -63.58 | 56.66 | 56.37 | -82.68 | -39.27 | 0.2845 | -- | -- | -- | -27.82 | -5.65 | -230.77 | -- | -37.12 | -- |
| Wellfully Ltd | 1.31m | -1.34m | 1.48m | 36.00 | -- | -- | -- | 1.13 | -0.003 | -0.003 | 0.0034 | -0.0034 | 0.377 | 0.3166 | 1.57 | -- | -38.36 | -175.88 | -- | -441.84 | 48.61 | -- | -101.74 | -266.08 | 0.2159 | -- | -- | -- | -42.78 | -5.87 | 12.98 | -- | 21.75 | -- |
| Melodiol Global Health Ltd | 19.60m | -35.52m | 1.65m | -- | -- | -- | -- | 0.084 | -0.2548 | -0.3762 | 0.1578 | -0.0172 | 0.6874 | 4.35 | 10.62 | -- | -124.57 | -102.92 | -387.77 | -152.32 | 15.38 | -- | -181.22 | -348.92 | 0.1594 | -6.71 | 1.73 | -- | 210.13 | 94.60 | -62.47 | -- | -46.82 | -- |
| Hexima Ltd | 193.85k | -753.18k | 1.67m | -- | -- | 0.6564 | -- | 8.62 | -0.0045 | -0.0045 | 0.0012 | 0.0152 | 0.0558 | -- | 0.2705 | -- | -21.67 | -72.85 | -26.54 | -193.37 | -- | -- | -388.54 | -213.09 | -- | -- | 0.00 | -- | 271.52 | -19.43 | 80.85 | -- | -- | -- |
| Hydration Pharmaceuticals Co Ltd | 15.14m | -12.22m | 3.96m | -- | -- | -- | -- | 0.2618 | -0.0627 | -0.0627 | 0.0776 | -0.002 | 1.18 | 1.61 | 6.60 | -- | -94.86 | -79.98 | -143.75 | -111.57 | 53.70 | 48.73 | -80.69 | -99.53 | 1.37 | -21.48 | 1.10 | -- | 10.34 | 19.27 | 23.61 | -- | -- | -- |
| Bod Science Ltd | 3.32m | -7.95m | 4.26m | -- | -- | -- | -- | 1.28 | -0.0557 | -0.0557 | 0.0235 | -0.0046 | 0.7533 | 2.42 | 8.05 | -- | -180.40 | -94.62 | -465.66 | -145.77 | 69.23 | 47.08 | -239.47 | -129.48 | 0.8319 | -- | 3.71 | -- | -34.70 | 23.20 | -47.10 | -- | 8.23 | -- |
| Cambium Bio Ltd | -28.22k | -366.01k | 4.60m | -- | -- | -- | -- | -- | -0.0012 | -0.0012 | -0.00009 | -0.0036 | -0.039 | -- | -- | -- | -50.58 | -49.44 | -- | -292.47 | -- | -- | -- | -118.34 | -- | -- | -- | -- | -- | -- | 60.86 | -- | -- | -- |
| Zelira Therapeutics Ltd | 1.62m | -36.43m | 5.33m | 8.00 | -- | -- | -- | 3.29 | -3.23 | -3.23 | 0.148 | -0.2063 | 0.0848 | 0.185 | 3.55 | -- | -193.14 | -27.71 | -243.04 | -28.81 | 82.28 | -- | -2,278.17 | -508.48 | 0.1488 | -22.80 | -- | -- | -80.95 | -0.3635 | 53.35 | -- | -- | -- |
| Invex Therapeutics Ltd | 837.95k | -6.01m | 6.01m | -- | -- | 1.14 | -- | 7.18 | -0.08 | -0.08 | 0.0112 | 0.0705 | 0.0521 | -- | 2.79 | -- | -37.38 | -- | -40.06 | -- | -- | -- | -717.76 | -- | -- | -- | 0.00 | -- | 379.22 | -- | -96.04 | -- | -- | -- |
